ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• eConsent: The Missing Ingredient To More Engaging Clinical Trials

  Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.

• Come To The Dark (Mode) Side

  Many of the decisions made by a product team start as suggestions from a user community of clinical professionals. While planning the development of a recently launched CTMS, a focus group was led where clinical professionals weighed in on potential improvements for a new system.

• Running Compliant Studies Without Enterprise EDC Overhead

  Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.

• Build Versus Buy: What's The Best Tech Tool For Study Activation?

  In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.

• Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC

  Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

• Why "Good Enough" Data Is Good Enough For Agentic AI

  Overcome 'data paralysis' and learn why you don’t need perfect data to start leveraging AI and its benefits, and why starting today is much better than waiting for 'perfect.'

• Cytokine Release Syndrome Monitoring

  Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.

• Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases

  Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.

• eCOA In Oncology Trials: A Tool To Simplify

  Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.

• Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis

  A major challenge in managing atopic dermatitis (AD) is the lack of objective tools to measure the impact of nocturnal scratching, but new digital measurement solutions could address this gap.